Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Neurosarcoidosis in Pediatric Patients: A Case Report and Review of Isolated and Systemic Neurosarcoidosis.
Finding NMO: The Evolving Diagnostic Criteria of Neuromyelitis Optica.
Interleukin 17 alone is not a discriminant biomarker in early demyelinating spectrum disorders.
Multiple sclerosis: Successful trial of amiselimod for multiple sclerosis.
Qualitative exploration of the benefits of group-based memory rehabilitation for people with neurological disabilities: implications for rehabilitation delivery and evaluation.
Rethinking the importance of paroxysmal and unusual symptoms as first clinical manifestation of multiple sclerosis: They do matter.
Study of communication in relapsing-remitting multiple sclerosis (RRMS): Disorders of the pragmatics of language, theory of mind and facial emotion processing.
Enantioselective total synthesis of the highly selective sphingosine-1-receptor VPC01091 by the Heck desymmetrization of a non-activated cyclopentene-fused spiro-pyrrolidinone.
RAGE-ligand axis: A new biomarker in multiple sclerosis, time for multicentre validation study!
Alteration of the cytokine signature by various TLR ligands in different T cell populations in MOG37-50 and MOG35-55-induced EAE in C57BL/6 mice.
Estimating epidemiological data of Multiple sclerosis using hospitalized data in Shandong Province, China.
An investigation of commonly prescribed stretches of the ankle plantarflexors in people with Multiple Sclerosis.
Antigen-oriented T cell migration contributes to myelin peptide induced-EAE and immune tolerance.
Ageing and recurrent episodes of neuroinflammation promote progressive eae in biozzi abh mice.
T cell cytokine signatures: Biomarkers in pediatric multiple sclerosis.
Treatment of ongoing autoimmune encephalomyelitis with activated B-cell progenitors maturing into regulatory B cells.
Novel Function of Extracellular Matrix Protein 1 in Suppressing Th17 Cell Development in Experimental Autoimmune Encephalomyelitis.
Effect of high-dose vitamin D3 supplementation on antibody responses against Epstein-Barr virus in relapsing-remitting multiple sclerosis.
New insights into the pharmacokinetics and pharmacodynamics of natalizumab treatment for patients with multiple sclerosis, obtained from clinical and in vitro studies.
An approach to comprehensive genome and proteome expression analyses in Schwann cells and neurons during peripheral nerve myelin formation.
Nonnative SOD1 trimer is toxic to motor neurons in a model of amyotrophic lateral sclerosis.
Imaging of progressive weakness or numbness of central or peripheral origin.
IL-27: a potential biomarker for responders to glatiramer acetate therapy.
ASSOCIATION BETWEEN DISABILITY AND QUALITY OF LIFE IN MULTIPLE SCLEROSIS PATIENTS IN AHVAZ, IRAN.
Cognitive impairment among patients with multiple sclerosis: associations with employment and quality of life.

Pages